Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT-2i and GLP-1RA Therapies”

3 trials

Showing 3 of 3 results

Not applicableStudy completedNCT05463705
What this trial is testing

Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications

Who this might be right for
DiabetesSGLT-2i and GLP-1RA TherapiesDiffusion of Responsibility+1 more
Brigham and Women's Hospital 1,580
Post-approval studies (Phase 4)Looking for participantsNCT07244003
What this trial is testing

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430
Not applicableNot Yet RecruitingNCT07723820
What this trial is testing

Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Retinopathy (DR)
Thammasat University Hospital 126

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation